홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

4-(2-Methoxypropan-2-yl)piperidine → 4-(2-chloro-8-((4-(2-methoxypropan-2-yl)piperidin-1-yl)methyl)-9-methyl-9H-purin-6-yl)morpholine

HRID 1945741
인쇄

반응식

HRID 1945741 반응식
[CH3:1][O:2][C:3]([CH:6]1[CH2:11][CH2:10][NH:9][CH2:8][CH2:7]1)([CH3:5])[CH3:4].Br[CH2:13][C:14]1[N:15]([CH3:30])[C:16]2[C:21]([N:22]=1)=[C:20]([N:23]1[CH2:28][CH2:27][O:26][CH2:25][CH2:24]1)[N:19]=[C:18]([Cl:29])[N:17]=2>>[Cl:29][C:18]1[N:17]=[C:16]2[C:21]([N:22]=[C:14]([CH2:13][N:9]3[CH2:10][CH2:11][CH:6]([C:3]([O:2][CH3:1])([CH3:5])[CH3:4])[CH2:7][CH2:8]3)[N:15]2[CH3:30])=[C:20]([N:23]2[CH2:24][CH2:25][O:26][CH2:27][CH2:28]2)[N:19]=1
참가 물질실험 절차출처 및 근거반응 노트

참가 물질

3

반응물 2

HCID 593528714-(2-Methoxypropan-2-yl)piperidineHCID 596034814-(8-(bromomethyl)-2-chloro-9-methyl-9H-purin-6-yl)morpholine

생성물 1

HCID 596057264-(2-chloro-8-((4-(2-methoxypropan-2-yl)piperidin-1-yl)methyl)-9-methyl-9H-purin-6-yl)morpholine수율 98.3%

실험 절차

4-(2-methoxypropan-2-yl)piperidine (0.12 g) was reacted with 4-(8-(bromomethyl)-2-chloro-9-methyl-9H-purin-6-yl)morpholine (0.25 g) via General Procedure E to give 300 mg of crude 4-(2-chloro-8-((4-(2-methoxypropan-2-yl)piperidin-1-yl)methyl)-9-methyl-9H-purin-6-yl)morpholine, of which 0.78 g was reacted with 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinolin-1-amine via General Procedure A to yield 12 mg of 155 as a white solid following reverse phase purification. MS (Q1) 531.3 (M)+

출처 및 근거

ORD 기록
ord-1f50f778be924ae89a7bb8bc69569e74
출처 데이터셋
uspto-grants-2013_03
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08394796B2

반응 노트

이 페이지에서참가 물질실험 절차출처 및 근거반응 노트